Výsledky vyhledávání - "Brian S Metzger"

674. Successful Management of ESBL Infections in Physician Outpatient Infusion Centers (POICs)

Autor: Ramesh V Nathan, Brian S Metzger, Jorge R Bernett, John S Adams, Richard L Hengel, Rishi Bhattacharyya, Claudia P Schroeder, Kimberly A Couch, Lucinda J Van Anglen

Publikováno v: Open Forum Infectious Diseases. 9

Background Infections with extended-spectrum β-lactamase (ESBL)-producing pathogens present treatment challenges with higher costs of care. Hospitalized patients (pts) with ESBL infections often require outpatient antimicrobial therapy (OPAT) follow

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::991fbb2a6f2a71ef68acc6223b585b45
https://doi.org/10.1093/ofid/ofac492.726

Zobrazit plný text záznamu

1327. Vancomycin Dosing by AUC24/MIC in Comparison to Traditional Trough Dosing in Office Infusion Centers (OICs)

Autor: Richard L Hengel, Kimberly A Couch, David N Rhoads, Claudia P. Schroeder, John S. Adams, Quyen Luu, Rishi Bhattacharyya, Lucinda J. Van Anglen, Brian S Metzger

Publikováno v: Open Forum Infectious Diseases

Background New vancomycin (VAN) guidelines have been published, with recommendations that dosing in patients (pts) with methicillin-resistant S. aureus (MRSA) infections be guided by VAN area under the concentration-time curve from 0 to 24 h to MIC r

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ee433a3dc0c1ad8080cb594a27a1f4c
https://doi.org/10.1093/ofid/ofaa439.1509

Zobrazit plný text záznamu

614. Long-Acting Lipoglycopeptides for the Treatment of Bone and Joint Infections and Bacteremia in Infectious Disease Outpatient Infusion Clinics

Autor: Brian S Metzger, Richard C Prokesch, Jorge R Bernett, Richard M Mandel, Ramesh V Nathan, Kent Stock, Thomas C Hardin, Claudia P Schroeder, Lucinda J Van Anglen

Publikováno v: Open Forum Infectious Diseases

Background Long-acting lipoglycopeptides (LGPs) are approved for the treatment of acute bacterial skin and skin-structure infections. Broad Gram-positive coverage and weekly dosing regimens are useful for other diagnoses, but real-world data supporti

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab8e9abe0f9a3bdd65eae7a1fa1b41a8
http://europepmc.org/articles/PMC7776532

Zobrazit plný text záznamu

1625. Real-World Outpatient Utilization of Ceftolozane/Tazobactam in Physician Office Infusion Centers (OICs)

Autor: Lucinda J Van Anglen, Ramesh V Nathan, Brian S Metzger, Quyen Luu, Claudia P Schroeder

Publikováno v: Open Forum Infectious Diseases

Background Ceftolozane/tazobactam (C/T) is indicated for the treatment (tx) of complicated Gram-negative infections including urinary tract infection (cUTI), intra-abdominal infection (cIAI), and hospital-acquired/ventilator-associated bacterial pneu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a34aeac45e35b142d5d1f95f3025e0b
https://doi.org/10.1093/ofid/ofaa439.1805

Zobrazit plný text záznamu

750. Serious Bacterial Infections: Successful Outpatient Management by Infectious Disease Physicians in Office Infusion Centers

Autor: Jorge R. Bernett, Thomas C. Hardin, Claudia P. Schroeder, Lucinda J. Van Anglen, Brian S Metzger, Barry Statner, Robin H. Dretler, Thomas K Sleweon, Richard M. Mandel, John S. Adams

Publikováno v: Open Forum Infectious Diseases

Background Patients with serious bacterial infections (SBI), identified as bone and joint infections (BJI), bacteremia/endocarditis, and central nervous system (CNS) infections are frequently discharged on outpatient parenteral antimicrobial therapy

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8086758e195c4499ca2b18dc77997544
https://doi.org/10.1093/ofid/ofz360.818

Zobrazit plný text záznamu

Plný text ve formátu HTML

313. Outpatient Treatment and Recurrence of Prosthetic Joint Infection (PJI) in Infectious Disease (ID) Physician Office Infusion Centers (POICs): A 2-Year Retrospective Multicenter Analysis

Autor: Richard C. Prokesch, Brian S Metzger, Richard M. Mandel, Jorge R. Bernett, Carson T Lo, Claudia P. Schroeder, John S. Adams, Lucinda J. Van Anglen, Thomas C. Hardin

Publikováno v: Open Forum Infectious Diseases

Background A significant complication of prosthetic joint replacement is the development of a PJI. Therapy includes prolonged IV antibiotics (IVAB), usually delivered in the outpatient setting. Follow-up (FU) in this population can be difficult, part

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6cb63077b05afc33e4afde3f4beca5fd
https://doi.org/10.1093/ofid/ofy210.324

Zobrazit plný text záznamu

2380. Healthcare Resource Utilization for High-Risk Patients Treated With Dalbavancin in Physician Office Infusion Centers (POICs)

Autor: Lucinda J. Van Anglen, H. Barry Baker, Robin H. Dretler, Barry Statner, Quyen Luu, Thomas C. Hardin, Brian S Metzger, Claudia P. Schroeder

Publikováno v: Open Forum Infectious Diseases

Background Medicare beneficiaries and patients (patients) ≥65 years comprise the highest risk for utilization of healthcare resources including emergency department (ED) visits and hospitalizations (hosp). Dalbavancin (DAL) is a long-acting lipogly

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae2902641b47e14c78af301ae45bffb9
https://doi.org/10.1093/ofid/ofy210.2033

Zobrazit plný text záznamu

Risk Factors for Methicillin-Resistance among Patients with Staphylococcus aureus Bacteremia at the Time of Hospital Admission

Autor: Nina M. Larsen, Susan M. Ray, Henry M. Blumberg, John E. McGowan, Brian S. Metzger, Nilton Alves de Rezende

Publikováno v: The American Journal of the Medical Sciences. 323:117-123

Background Community-acquired infections caused by methicillin-resistant Staphylococcus aureus (MRSA) seem to be increasing. Characteristics permitting recognition of patients with such strains would aid infection control efforts and choice of empiri

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2153837dd04d9733a549d131f22070c
https://doi.org/10.1097/00000441-200203000-00001

Zobrazit plný text záznamu

Successful Establishment of an Antimicrobial Stewardship Program (ASP) for Outpatient Parenteral Antimicrobial Therapy (OPAT)

Autor: Lucinda J. Van Anglen, Kimberly A Couch, Ramesh V Nathan, Claudia P. Schroeder, Brian S Metzger, Robin H. Dretler, John S. Adams, Quyen Luu

Publikováno v: Open Forum Infectious Diseases

Background IDSA guidelines for implementing an ASP were published in 2016 with required standards by The Joint Commission for hospitals beginning January, 2017. To date, no guidelines have been established in the US for ASP specific to OPAT. Using cu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::954786f9c7b0d5d487f636ff0299b6b6
http://europepmc.org/articles/PMC5631884

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání